ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1780

Association Between Chondrocyte Hypertrophy and Angiogenesis of Cartilage in Osteoarthritis

Laurence Pesesse1, Christelle Sanchez2, Jean-Pierre Delcour3, Caroline Baudouin4, Philippe Msika4 and Yves Henrotin5, 1Bone and Cartilage Research Unit, University of Liège, Liège, Belgium, 2Bone and Cartilage Research Unit, University of Liège, Liege, Belgium, 3Orthopedic surgery, Centre hospitalier du Bois de l'Abbaye, Seraing, Belgium, 4IRD Direction, Laboratoires Expanscience, Epernon, France, 5University of Liège, Bone and Cartilage Research Unit, Liège, Belgium

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Angiogenesis, cartilage and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Chondrocyte hypertrophy is commonly observed in OA cartilage, associated with matrix mineralization and vascularization. In our previous work, we demonstrated that hypertrophic differentiation of chondrocytes is initiated by serum-enriched medium in long-term culture in alginate beads suggesting a role played by blood supply in the hypertrophic differentiation of chondrocytes in OA.

As hypertrophic differentiation of chondrocytes is an important feature of osteoarthritis (OA), we developed a model of culture in order to study the functional consequences of hypertrophic OA chondrocytes. The aim of this study was to investigate the link between hypertrophic differentiation of chondrocytes and angiogenesis in OA in order to demonstrate that OA hypertrophic chondrocytes expressed an angiogenic phenotype and that some specific factors could be implicated in both processes.

Methods:

Articular OA chondrocytes were cultured for 28 days in alginate beads in medium containing 2% Ultroser G (UG) or 10% Fetal Bovine Serum (FBS). DNA was quantified by fluorimetry. The expression of hypertrophy markers genes type X collagen (col10a1), runt-related factor 2 (runx2) and matrix metalloprotease 13 (MMP13) and a screening of angiogenic factors was evaluated by RT‐PCR. Alkaline phosphatase (AP) activity and 5’phosphodiesterase activity of NTPPPH were quantified by specific enzymatic methods. Non-hypertrophic and hypertrophic human OA chondrocyte conditioned media were used to perform functional tests with huvecs: migration, invasion and wound healing assays. Data were analyzed by one-way ANOVA.

Results:

In alginate beads, chondrocytes cultivated in serum-supplemented medium underwent a hypertrophic differentiation process characterized by significant increased expression of hypertrophic markers and mineralization enzymes (col10a1: p<0.05; runx2: p<0.01; MMP13: p<0.001; PA: p<0.001; NTPPPH: p<0.001). Functional angiogenesis assays showed that chondrocyte hypertrophy positively influenced migration (p<0.0001), invasion (p<0.0001) and wound healing (p=0.0005) of endothelial cells. Among the screened angiogenic factors, bone sialoprotein (BSP) was highly upregulated in hypertrophic chondrocytes (p<0.05).

Conclusion:

Our culture model allowed to mimic hypertrophic differentiation of chondrocytes and to investigate the relationship between this process and functional invasion and migration of endothelial cells, two functional steps in the process of angiogenesis. The results obtained in this study highlighted BSP as a specific factor that could be implicated in hypertrophic differentiation of chondrocytes and cartilage angiogenesis.


Disclosure:

L. Pesesse,
None;

C. Sanchez,
None;

J. P. Delcour,
None;

C. Baudouin,
None;

P. Msika,
None;

Y. Henrotin,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-chondrocyte-hypertrophy-and-angiogenesis-of-cartilage-in-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology